No results for ‘’
Fredun Pharmaceuticals Ltd
NSE: BSE: 539730
₹1412.20
(3.35%)
Sat, 12 Sept 2026, 08:58 am
Market Cap (in Cr)2426.38
PE Ratio51.31
Dividend0.02
Health Technology
Pharmaceuticals: Major
24.5KFredun Pharmaceuticals Cashflow
| Particulars | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -8.04M | -11.36M | -12.85M | -13.30M | -18.79M | -20.04M | -21.57M | -28.09M | -37.96M | -50.39M |
| Accumulated depreciation, total | -62.92M | -74.28M | -87.13M | -100.43M | -55.23M | -75.05M | -96.38M | -124.03M | -161.45M | -272.97M |
| Cash from operating activities | 17.72M | 24.71M | 150.75M | -96.57M | -149.44M | -40.06M | -70.49M | -234.40M | -135.89M | -514.39M |
| Funds from operations | 20.25M | 27.22M | 28.92M | 52.17M | 40.31M | 64.80M | 117.24M | 198.77M | 245.68M | 327.10M |
| Net income (cash flow) | 10.69M | 14.27M | 17.51M | 44.60M | 19.02M | 20.15M | 63.35M | 108.07M | 156.23M | 197.39M |
| Depreciation & amortization (cash flow) | 8.04M | 11.36M | 12.85M | 13.30M | 18.79M | 20.04M | 21.57M | 28.09M | 37.96M | 50.39M |
| Depreciation/depletion | 8.04M | 11.36M | 12.85M | 13.30M | 18.66M | 19.82M | 21.33M | 27.65M | 37.42M | 49.91M |
| Amortization | — | — | — | — | 126.80K | 222.43K | 235.00K | 443.00K | 537.00K | 486.00K |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 1.49M | 4.36M | 541.00K | 24.12M | 2.94M | 3.48M |
| Non-cash items | -6.14M | -6.40M | -1.44M | -5.74M | -3.43M | -3.61M | 32.00M | 38.99M | 48.55M | 72.93M |
| Changes in working capital | -2.53M | -2.51M | 121.83M | -148.74M | -189.75M | -104.86M | -187.73M | -433.18M | -381.57M | -841.49M |
| Cash from investing activities | -59.88M | -71.34M | -82.13M | -52.52M | -14.93M | -13.88M | -41.29M | -94.05M | -76.39M | -63.54M |
| Capital expenditures | -73.94M | -71.34M | -82.13M | -164.01M | -14.93M | -13.88M | -42.72M | -94.95M | -76.39M | -61.06M |
| Capital expenditures - fixed assets | -73.94M | -71.34M | -82.13M | -164.01M | -14.66M | -13.80M | -42.72M | -91.98M | -76.39M | -61.06M |
| Capital expenditures - other assets | — | 0 | 0 | 0 | -265.00K | -82.20K | 0 | -2.96M | — | — |
| Cash from financing activities | 50.03M | 40.25M | -61.58M | 149.22M | 180.75M | 34.72M | 121.35M | 344.58M | 196.43M | 614.92M |
| Free cash flow | -56.22M | -46.63M | 68.61M | -260.58M | -164.11M | -53.85M | -113.21M | -326.39M | -212.28M | -575.46M |